Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: a propensity score adjusted retrospective cohort study

Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: a propensity score adjusted retrospective cohort study

Early treatment of high-risk COVID-19 patients may prevent disease progression. However, there are limited data to support treatment of hospitalized or fully vaccinated patients with mild-to-moderate disease. In this retrospective cohort study, we studied the effect of early use of sotrovimab and re...

Full description

Bibliographic Details
Main Authors: Koh, Lin Pin, Chua, Siang Li, Vasoo, Shawn, Toh, Matthias Paul Han Sim, Cutter, Jeremy Nicholas, Nah, Puay Hoon, Leo, Yee Sin, Tay, Jun Xin, Young, Barnaby Edward, Lye, David C., Ong, Sean W. X.
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2023
Subjects:
Science::Medicine
COVID‐19
Early‐Treatment
Online Access:https://hdl.handle.net/10356/172156

Similar Items

Similar Items